What We Do

Prenome is a women’s health company focused on improving clinical outcomes with leading-edge technologies in data-driven personalized medicine.

Many women’s health conditions are preventable and easy to diagnose with personalized medicine. Prenome helps women by providing them with better tools to know their risks and empower them to manage them. Find out more>>

Prenome's clinical studies aim to predict and prevent common women's health issues. Prenome's premiere study, OneinSeven, is a research study, examining the genetic and lifestyle risk factors associated with gestational diabetes.

Leveraging large individual-level datasets, our OneinSeven clinical study, and AI-powered capabilities, Prenome is building a highly integrated pipeline to generate our patented combined risk score which integrates genetics and epigenetics to predict gestational diabetes early on in pregnancy.

OneinSeven study

OneinSeven is a research study, examining the genetic and lifestyle risk factors associated with gestational diabetes. This study will generate proprietary polygenic risk scores (PRS) that calculate the risk of development of gestational diabetes in pregnant persons based on their genetic profile and sociodemographic information

Sign Up